The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6

Veterinary Research

Volumn 44, Issue 1, 2013, Pages

  Irvine, Katherine Lucy ^a   Hopkins, Lee Jason ^a   Gangloff, Monique ^a   Bryant, Clare Elizabeth ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); EQUIDAE; MAMMALIA; MURINAE; MUS; STAPHYLOCOCCUS AUREUS;

LIGAND; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TEICHOIC ACID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ANIMAL; CHEMISTRY; CONFORMATION; GENETICS; HEK293 CELL LINE; HORSE; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; VETERINARY; ANIMAL DISEASE; ARTICLE; CELL STRAIN HEK293;

ANIMALS; HEK293 CELLS; HORSES; HUMANS; LIGANDS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MOLECULAR CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 84879822714     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-44-50     Document Type: Article

References (38)

1. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Kang J, Nan X, Jin M, Youn S, Ryu Y, Mah S, Han S, Lee H, Paik S, Lee J, Immunity 2009 31 873 884 10.1016/j.immuni.2009.09.018 19931471
2. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Jin M, Kim S, Heo J, Lee M, Kim H, Paik S, Lee H, Lee J, Cell 2007 130 1071 1082 10.1016/j.cell.2007.09.008 17889651 (Pubitemid 47410281)
3. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Zahringer U, Lindner B, Inamura S, Heine H, Alexander C, Immunobiology 2008 213 205 224 10.1016/j.imbio.2008.02.005 18406368
4. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. Omueti K, Beyer J, Johnson C, Lyle E, Tapping R, J Biol Chem 2005 280 36616 36625 10.1074/jbc.M504320200 16129684 (Pubitemid 41587738)
5. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. Takeuchi O, Hoshino K, Akira S, J Immunol 2000 165 5392 5396 11067888
6. The importance of Toll-like receptor 2 polymorphisms in severe infections. Texereau J, Chiche J, Taylor W, Choukroun G, Comba B, Mira J, Clin Infect Dis 2005 41 Suppl 7 408 S415 16237639
7. Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. Bochud P, Hawn T, Siddiqui M, Saunderson P, Britton S, Abraham I, Argaw A, Janer M, Zhao L, Kaplan G, Aderem A, J Infect Dis 2008 197 253 261 10.1086/524688 18177245 (Pubitemid 351263444)
8. Association between respiratory disease and bacterial and viral infections in British racehorses. Wood J, Newton J, Chanter N, Mumford J, J Clin Microbiol 2005 43 120 126 10.1128/JCM.43.1.120-126.2005 15634959 (Pubitemid 40096288)
9. Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gram-negative infections, and single organism and mixed infections. Corley K, Pearce G, Magdesian K, Wilson W, Equine Vet J 2007 39 84 89 10.2746/042516407X157585 17228602 (Pubitemid 46047557)
10. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Figueiredo M, Vandenplas M, Hurley D, Moore J, Vet Immunol Immunopathol 2009 127 125 134 10.1016/j.vetimm.2008.09.028 19019456
11. Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood. Declue A, Johnson P, Day J, Amorim J, Honaker A, Vet J 2011 192 455 460 21974971
12. The molecular basis of the host response to lipopolysaccharide. Bryant C, Spring D, Gangloff M, Gay N, Nat Rev Microbiol 2010 8 8 14 19946286
13. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. Walsh C, Gangloff M, Monie T, Smyth T, Wei B, McKinley T, Maskell D, Gay N, Bryant C, J Immunol 2008 181 1245 1254 18606678
14. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. Golenbock D, Hampton R, Qureshi N, Takayama K, Raetz C, J Biol Chem 1991 266 19490 19498 1918061 (Pubitemid 21908258)
15. Characterization of an equine macrophage cell line: application to studies of EIAV infection. Fidalgo-Carvalho I, Craigo J, Barnes S, Costa-Ramos C, Montelaro R, Vet Microbiol 2009 136 8 19 10.1016/j.vetmic.2008.10.010 19038510
16. SWISS-MODEL: an automated protein homology-modeling server. Schwede T, Kopp J, Guex N, Peitsch M, Nucleic Acids Res 2003 31 3381 3385 10.1093/nar/gkg520 12824332 (Pubitemid 37442164)
17. The SWISS-MODEL Repository: new features and functionalities. Kopp J, Schwede T, Nucleic Acids Res 2006 34 Database issue 315 D318 16381875
18. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Arnold K, Bordoli L, Kopp J, Schwede T, Bioinformatics 2006 22 195 201 10.1093/bioinformatics/bti770 16301204 (Pubitemid 43205406)
19. The SWISS-MODEL repository and associated resources. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T, Nucleic Acids Res 2009 37 Database issue 387 D392 18931379
20. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. Wang J, Manning B, Wu Q, Blankson S, Bouchier-Hayes D, Redmond H, J Immunol 2003 170 795 804 12517943 (Pubitemid 36070531)
21. Lipoteichoic acid (LTA) of streptococcus pneumoniae and staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. Schroder N, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Gobel U, Weber J, Schumann R, J Biol Chem 2003 278 15587 15594 10.1074/jbc.M212829200 12594207 (Pubitemid 36799667)
22. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. Figueroa L, Xiong Y, Song C, Piao W, Vogel S, Medvedev A, J Immunol 2012 188 4506 4515 10.4049/jimmunol.1200202 22474023
23. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning C, J Biol Chem 1999 274 17406 17409 10.1074/jbc.274.25.17406 10364168 (Pubitemid 29283245)
24. Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. Bunk S, Sigel S, Metzdorf D, Sharif O, Triantafilou K, Triantafilou M, Hartung T, Knapp S, von Aulock S, J Immunol 2010 185 3708 3717 10.4049/jimmunol.0901660 20713893
25. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. Guan Y, Ranoa D, Jiang S, Mutha S, Li X, Baudry J, Tapping R, J Immunol 2010 184 5094 5103 10.4049/jimmunol.0901888 20348427
26. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. O'Neill L, Bowie A, Nat Rev Immunol 2007 7 353 364 10.1038/nri2079 17457343 (Pubitemid 46674493)
27. Gene conversion limits divergence of mammalian TLR1 and TLR6. Kruithof E, Satta N, Liu J, Dunoyer-Geindre S, Fish R, BMC Evol Biol 2007 7 148 10.1186/1471-2148-7-148 17727694 (Pubitemid 350119679)
28. Human but not murine toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. Grabiec A, Meng G, Fichte S, Bessler W, Wagner H, Kirschning C, J Biol Chem 2004 279 48004 48012 10.1074/jbc.M405311200 15342637 (Pubitemid 39540953)
29. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S, Nature 2002 420 324 329 10.1038/nature01182 12447441 (Pubitemid 35398188)
30. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Horng T, Barton G, Flavell R, Medzhitov R, Nature 2002 420 329 333 10.1038/nature01180 12447442 (Pubitemid 35398189)
31. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. Kenny E, Talbot S, Gong M, Golenbock D, Bryant C, O'Neill L, J Immunol 2009 183 3642 3651 10.4049/jimmunol.0901140 19717524
32. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. Santos-Sierra S, Deshmukh S, Kalnitski J, Kuenzi P, Wymann M, Golenbock D, Henneke P, EMBO J 2009 28 2018 2027 10.1038/emboj.2009.158 19574958
33. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. Verstak B, Nagpal K, Bottomley S, Golenbock D, Hertzog P, Mansell A, J Biol Chem 2009 284 24192 24203 10.1074/jbc.M109.023044 19592497
34. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Mansell A, Smith R, Doyle S, Gray P, Fenner J, Crack P, Nicholson S, Hilton D, O'Neill L, Hertzog P, Nat Immunol 2006 7 148 155 16415872 (Pubitemid 43135880)
35. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. Gray P, Dunne A, Brikos C, Jefferies C, Doyle S, O'Neill L, J Biol Chem 2006 281 10489 10495 10.1074/jbc.M508892200 16439361 (Pubitemid 43864588)
36. Identification and subcellular localization of apolipoprotein N-acyltransferase in escherichia coli. Gupta S, Wu H, FEMS Microbiol Lett 1991 62 37 41 2032623
37. Environment-mediated accumulation of diacyl lipoproteins over their triacyl counterparts in staphylococcus aureus. Kurokawa K, Kim M, Ichikawa R, Ryu K, Dohmae N, Nakayama H, Lee B, Marche P, J Bacteriol 2012 194 3299 3306 10.1128/JB.00314-12 22467779
38. Mediators and vascular effects in response to endotoxin. Olson N, Hellyer P, Dodam J, Br Vet J 1995 151 489 522 10.1016/S0007-1935(05)80023-5 8556312